Shantha Biotechnics is an Indian biotechnology company based in Hyderabad. It is the first Indian company to develop, manufacture and market a recombinant human healthcare product in India. The company is a wholly owned Subsidiary of Sanofi group.
The genesis of Shantha Biotechnics Ltd can be traced back to the initiatives of Dr. K I Varaprasad Reddy and Mr. Khalil Ahmed; Dr. Varaprasad and Mr. Khalil Ahmed established the company in 1993 with th...
More
Shantha Biotechnics is an Indian biotechnology company based in Hyderabad. It is the first Indian company to develop, manufacture and market a recombinant human healthcare product in India. The company is a wholly owned Subsidiary of Sanofi group.
The genesis of Shantha Biotechnics Ltd can be traced back to the initiatives of Dr. K I Varaprasad Reddy and Mr. Khalil Ahmed; Dr. Varaprasad and Mr. Khalil Ahmed established the company in 1993 with the sole purpose of developing efficacious but cost effective vaccines and therapeutics.
The project began modestly as an R&D; outfit at the Osmania University under the industry-university interactive programme in 1993 and later at the Center for Cellular and Molecular Biology until an independent R&D; facility was built.
In 2009, French pharma major Sanofi vaccine division Sanofi Pasteur has acquired Hyderabad-based Shantha Biotechnics, which has been valued at euro 550 million (over Rs 3,770 crore).
Genome Valley
Less
